Lee G Wilke, MD, FACS
Professor
- Director, UW Health Breast Center
- Professor, Division of Surgical Oncology
- Hendricks Chair in Breast Cancer Surgery Research
wilke@surgery.wisc.edu
(608) 263-1164
600 Highland Avenue
Box 7375 Clinical Science Center
Madison, WI 53792
Education
- MD, Duke University, Durham, NC, 1993
- Residency in Surgery, University of Michigan, Ann Arbor, Michigan, 1993-2000
- ACS Resident Research Fellow in Immunotherapy, University of Michigan, Ann Arbor, MI 1996-1998
Clinical Specialties
Dr. Wilke is certified by the American Board of Surgery and specializes in benign and malignant diseases of the breast; sentinel lymph-node mapping; neoadjuvant therapy for breast cancer; and oncoplastic breast surgery.
Dr. Wilke provides a wide range of services including Axillary Lymph Node Dissection, Core Needle Biopsy, Lumpectomy or Partial Mastectomy, Modified Radical Mastectomy, Needle-localized Biopsy, Needle-localized Excision, Sentinel Lymph Node Biopsy, Simple Mastectomy, Skin-sparing and/or Nipple-sparing Mastectomy.
Research Interests
Dr. Wilke’s principal research interest is in clinical trials seeking novel methods of treating patients with breast cancer. Dr. Wilke is a member of the Commission on Cancer. She is also a collaborator on multiple grants and trials evaluating novel treatments for breast cancer.
Recent Publications
-
- Outcomes for Patients with Residual Stage II/III Breast Cancer Following Neoadjuvant Chemotherapy (AFT-01).
- Stankowski-Drengler TJ, Schumacher JR, Hanlon B, Livingston-Rosanoff D, Van de Walle K, Greenberg CC, Wilke LG, Neuman HB
- Ann. Surg. Oncol. 2020 Jan 03;
- [PubMed ID: 31900808]
-
- Breast Cancer Found Incidentally After Reduction Mammaplasty in Young Insured Women.
- Vande Walle K, Yang DY, Stankowski-Drengler TJ, Livingston-Rosanoff D, Fernandes-Taylor S, Schumacher JR, Wilke LG, Greenberg CC, Neuman HB
- Ann. Surg. Oncol. 2019 Dec; 26(13): 4310-4316
- [PubMed ID: 31538286]
-
- Time to initiation of neo-adjuvant chemotherapy for breast cancer treatment does not influence patient survival: A study of US breast cancer patients.
- Livingston-Rosanoff D, Hanlon B, Marka N, Vande Walle K, Stankowski-Drengler T, Schumacher J, Greenberg CC, Neuman H, Wilke LG
- Breast J 2019 Sep 12;
- [PubMed ID: 31513322]
-
- Impact of Pre-Transplant Malignancy on Outcomes After Kidney Transplantation: United Network for Organ Sharing Database Analysis.
- Livingston-Rosanoff D, Foley DP, Leverson G, Wilke LG
- J. Am. Coll. Surg. 2019 Dec; 229(6): 568-579
- [PubMed ID: 31666186]
-
- A Randomized Controlled Trial Evaluating the Impact of Pre-Consultation Information on Patients' Perception of Information Conveyed and Satisfaction with the Decision-Making Process.
- Stankowski-Drengler TJ, Tucholka JL, Bruce JG, Steffens NM, Schumacher JR, Greenberg CC, Wilke LG, Hanlon B, Steiman J, Neuman HB
- Ann. Surg. Oncol. 2019 Oct; 26(10): 3275-3281
- [PubMed ID: 31342375]